EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Unexpected curative effect of PD-1 inhibitor in gastric cancer with brain metastasis: A case report

Qijun Wang, Zhewei Shen, Mengxi Ge, Jie Xu, Xin Zhang, Wei Zhu, Jie Liu, Wei Hua, Ying Mao

Frontiers in Oncology · 16.02.2023 · 13

DOI: 10.3389/fonc.2023.1042417 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Frontiers in Oncology, online erschienen am 16.02.2023. Verfasst von Qijun Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Huashan Hospital, Fudan University, Shanghai, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Gastric cancer (GC) is the third most common cause of cancer-related death in the world. Several clinical trials have proven that the use of PD-1/PD-L1 inhibitors can improve the survival of late-stage GC patients and is suggested in NCCN and CSCO guidelines. However, the correlation between PD-L1 expression and the response to PD-1/PD-L1 inhibitors is still controversial. GC rarely develops brain metastasis (BrM) and currently there is no therapeutic protocol for GC BrMs. Case presentation We report a case of a 46-year-old male suffering from GC with PD-L1 negative BrMs 12 years after GC resection and 5 cycles of chemotherapy. We treated the patient with the immune checkpoint inhibitor (ICI) pembrolizumab and all metastatic tumors achieved a complete response (CR). A durable remission of the tumors is confirmed after 4 years of follow-up.

Conclusion

We shared a rare case with PD-L1 negative GC BrM responsive to PD-1/PD-L1 inhibitors, the mechanism of which is still unclear. The protocol of therapeutic choice for late-stage GC with BrM is urgently needed. And we are expecting biomarkers other than PD-L1 expressions to predict the efficacy of ICI treatment.

Schlagwörter

Stichwörter der Autor:innen

PD-1 inhibitorsPD-1/PD-L1brain metastasisgastric cancerimmunotherapy

Autor:innen und Institutionen

  • Department of Neurosurgery, Huashan Hospital, Fudan University, Shanghai, China.
  • National Center for Neurological Disorders, Shanghai, China.
  • Shanghai Key Laboratory of Brain Function Restoration and Neural Regeneration, Shanghai, China.
  • Neurosurgical Institute of Fudan University, Shanghai, China.
  • Shanghai Clinical Medical Center of Neurosurgery, Shanghai, China.
  • Department of Oncology, Huashan Hospital, Fudan University, Shanghai, China.

Zitieren

APA

Wang, Q., Shen, Z., Ge, M., Xu, J., Zhang, X., Zhu, W., Liu, J., Hua, W., & Mao, Y. (2023). Unexpected curative effect of PD-1 inhibitor in gastric cancer with brain metastasis: A case report. Frontiers in Oncology, 13. https://doi.org/10.3389/fonc.2023.1042417

Vancouver

Wang Q, Shen Z, Ge M, Xu J, Zhang X, Zhu W, et al. Unexpected curative effect of PD-1 inhibitor in gastric cancer with brain metastasis: A case report. Frontiers in Oncology. 2023;13. doi:10.3389/fonc.2023.1042417

BibTeX
@article{Wang2023,
  author = {Wang, Qijun and Shen, Zhewei and Ge, Mengxi and Xu, Jie and Zhang, Xin and Zhu, Wei and Liu, Jie and Hua, Wei and Mao, Ying},
  title = {Unexpected curative effect of PD-1 inhibitor in gastric cancer with brain metastasis: A case report},
  journal = {Frontiers in Oncology},
  year = {2023},
  volume = {13},
  doi = {10.3389/fonc.2023.1042417}
}
Kostenlos starten →